Dosage Regimen: Multiple Oral Dosage
Oral Cavity
Gene Therapy
Multiple Allele Traits
Group Therapy
Multiple Regression
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 13, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
1Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, 44791 Bochum, Germany.
New oral medications are transforming multiple sclerosis (MS) treatment. This review covers the mechanisms, clinical data, and safety of fingolimod, dimethylfumarate, teriflunomide, and cladribine, with others in development.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: